Eptifibatide Acetate

Premium Synthetic Cyclic Heptapeptide | High-Selectivity GP IIb/IIIa Antagonist

Product Description

Eptifibatide Acetate is a high-purity synthetic cyclic heptapeptide that serves as a highly selective platelet glycoprotein IIb/IIIa (GP IIb/IIIa) receptor antagonist. Verified by HPLC with a purity of ≥99.0%, it exhibits potent antiplatelet aggregation activity. By competitively binding to receptors, it effectively blocks fibrinogen interactions, making it a critical material for cardiovascular pharmaceutical R&D.

Core Advantages

High Purity & Quality ControlStrict monitoring of related substances and bacterial endotoxins (≤5.0 EU/mg), fully complying with industrial and pharmaceutical R&D standards.

Stable PerformanceAdvanced synthesis ensures consistent activity. Proper cold-chain storage at 2-8°C guarantees a 24-month shelf life with minimal degradation.

Flexible CustomizationSupports small-batch R&D needs (1g, 5g, 10g) up to industrial bulk supply (1KG bags or 25KG drums).

Key Functions & Applications

As a specific antithrombotic agent, it is widely utilized in:

Pharmaceutical R&D: Development of drugs for Acute Coronary Syndrome (ACS) and PCI procedures.
Scientific Research: In vitro studies on platelet activation and thrombosis mechanisms.
Biopharm Production: Key intermediate for high-purity bulk pharmaceutical synthesis.

Wholesale FAQ

How is the purity verified?

We use internationally recognized HPLC (High Performance Liquid Chromatography) for every batch. A detailed COA is provided with each shipment.

What are the logistics requirements?

Due to the peptide structure, we utilize professional cold chain transportation (2-8°C) with insulated packaging and temperature tracking for global delivery.

Is this for clinical use?

This product is intended for industrial use or scientific research only. It is not for direct human clinical treatment or diagnostic use.